JNJ: Johnson & Johnson Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 375,130.88
Enterprise Value ($M) 390,657.88
Book Value ($M) 71,490.00
Book Value / Share 29.71
Price / Book 5.25
NCAV ($M) -44,011.00
NCAV / Share -18.29
Price / NCAV -8.52

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.32

Liquidity (mrq)
Quick Ratio 1.03
Current Ratio 1.26

Balance Sheet (mrq) ($M)
Current Assets 71,551.00
Assets 193,671.00
Liabilities 115,562.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 88,821.00
Operating Income 21,249.00
Net Income 14,066.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 24,266.00
Cash from Investing -18,599.00
Cash from Financing -3,132.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-30 887,061 5,461,529 16.24
2025-04-29 882,148 3,838,319 22.98
2025-04-28 1,267,062 4,275,834 29.63

(click for more detail)

Similar Companies
EBS – Emergent BioSolutions Inc. ELAN – Elanco Animal Health Incorporated
HYAC – Haymaker Acquisition Corp. 4 LLY – Eli Lilly and Company
MRK – Merck & Co., Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Johnson & Johnson